Can Saxenda (Liraglutide) Cause Heart Palpitations?

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 18th, 2026.

Published on July 16th, 2026. Updated on July 18th, 2026.

Medications 5 min

Key takeaways

  • Heart palpitations have been reported by some people taking Saxenda (liraglutide), though they are not among the most common side effects.

  • Liraglutide can increase resting heart rate slightly, which may contribute to a fluttering or racing sensation in some users.

  • Most palpitations linked to Saxenda are mild and temporary, but chest pain, fainting, or a very rapid heart rate warrant urgent medical attention.

  • Dehydration from nausea or vomiting, common early Saxenda side effects, can also trigger palpitations independently of the drug itself.

  • A licensed clinician can help determine whether palpitations are related to Saxenda or another cause and whether any adjustment is needed.

What Saxenda Does in the Body

Saxenda is the brand name for liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for chronic weight management. It works by mimicking a natural gut hormone that signals fullness, slows stomach emptying, and helps regulate blood sugar. Because GLP-1 receptors are found not only in the gut and brain but also in cardiac tissue, liraglutide can influence heart function in ways that go beyond simple weight loss.

When liraglutide binds to receptors in the heart and nervous system, it may slightly increase the rate at which the heart beats at rest. Clinical trials for both Saxenda and its higher-dose cousin Ozempic (semaglutide) have consistently noted this modest heart rate uptick. For most people the change is small, roughly two to three beats per minute on average, and causes no noticeable symptoms. For others, particularly those sensitive to changes in heart rhythm, it may produce a fluttering or pounding sensation in the chest.

The Link Between Liraglutide and Palpitations

Palpitations are the subjective awareness of your own heartbeat. They can feel like fluttering, pounding, skipping, or racing and may be felt in the chest, throat, or neck. While palpitations are not listed as a primary warning in Saxenda's prescribing information, they appear in post-marketing surveillance reports and in patient accounts shared with the FDA's adverse event database.

Several mechanisms may explain why some Saxenda users experience palpitations:

  • Elevated resting heart rate. GLP-1 agonists have a direct chronotropic effect, meaning they can speed up the heart. Even a small increase may be noticeable to sensitive individuals.
  • Sympathetic nervous system activation. Liraglutide may stimulate the sympathetic nervous system, which governs the fight-or-flight response and can produce a racing heartbeat.
  • Electrolyte shifts. Rapid changes in eating habits or calorie intake after starting Saxenda can alter potassium and magnesium levels, both of which affect heart rhythm.
  • Dehydration. Nausea and vomiting, very common in the first weeks of treatment, reduce fluid volume and can make the heart work harder to maintain circulation.

When Palpitations Are More Concerning

Not all palpitations carry the same risk. Understanding the difference between benign and potentially serious episodes helps you decide how quickly to seek care.

Feature

Likely Benign

Seek Care Promptly

Duration

A few seconds to minutes

More than 15 minutes or recurring

Associated symptoms

None, or mild lightheadedness

Chest pain, shortness of breath, fainting

Heart rate feel

Slightly fast but regular

Very rapid, irregular, or pounding

Timing

Linked to nausea or eating

Occurs at rest without obvious trigger

History

No prior heart condition

Known arrhythmia or structural heart disease

If your palpitations fall into the right-hand column, stop what you are doing and seek emergency evaluation. Do not wait for a scheduled appointment. People with a history of arrhythmias, prolonged QT syndrome, or structural heart disease should discuss these risks with a clinician before starting Saxenda.

Managing Palpitations While on Saxenda

If you notice mild palpitations after starting liraglutide, several practical steps may help reduce their frequency and severity.

Hydrate consistently. Aim for at least eight cups of water daily, more if nausea or vomiting has been a problem. Electrolyte drinks without added sugar can help if gastrointestinal side effects have been significant.

Eat small, frequent meals. Large meals can trigger both nausea and a reflex rise in heart rate. Smaller portions spread throughout the day reduce the digestive burden and may settle palpitations tied to eating.

Limit caffeine and alcohol. Both substances can independently raise heart rate and worsen palpitations. Reducing or eliminating them while your body adjusts to Saxenda is a reasonable precaution.

Track your symptoms. Note when palpitations occur, how long they last, and what you were doing. This log gives your clinician useful information and can help distinguish drug-related effects from unrelated causes like anxiety or caffeine intake.

Follow the dose escalation schedule. Saxenda is started at a low dose and increased gradually over five weeks specifically to minimize side effects. Rushing the escalation increases the likelihood of nausea, dehydration, and cardiac symptoms.

What the Research Says About Saxenda and Heart Health

Despite the possibility of palpitations, the overall cardiovascular picture for liraglutide is broadly reassuring for people without pre-existing arrhythmias. The LEADER trial, a large cardiovascular outcomes study involving more than 9,000 participants with type 2 diabetes and high cardiovascular risk, found that liraglutide reduced the rate of major adverse cardiovascular events compared with placebo. Heart attack risk and cardiovascular death were both lower in the liraglutide group.

However, heart rate was consistently higher in liraglutide-treated participants throughout that trial. Researchers continue to study whether this sustained increase in resting heart rate poses any long-term risk, particularly for people without the protective effects of weight loss or improved blood sugar control.

For individuals using Saxenda strictly for weight management rather than diabetes, the cardiovascular risk-benefit calculation may differ slightly. Discussing your complete cardiac history with a clinician before starting treatment is always the right first step. With 22 million-plus AI consultations completed and 99.2% treatment plan alignment with board-certified physicians, Doctronic provides a fast, affordable way to review your options any time of day or night.

Frequently Asked Questions

Palpitations are not listed among the most frequent Saxenda side effects, but they have been reported in post-marketing data. Nausea, diarrhea, and constipation are far more common. If you notice a fluttering or racing heartbeat after starting liraglutide, mention it to your clinician at your next visit.

Clinical trials showed a modest average increase in resting heart rate of about two to three beats per minute in some participants. This effect is generally not permanent and may resolve after stopping the medication. Regular monitoring by a clinician helps ensure your heart rate stays within a safe range throughout treatment.

Do not stop Saxenda without consulting your clinician first. Mild, brief palpitations may not require stopping the drug. However, if palpitations are accompanied by chest pain, shortness of breath, or fainting, seek emergency care right away and inform your prescribing provider as soon as possible.

Yes. Nausea and vomiting, which are common early in Saxenda treatment, can lead to dehydration. Dehydration reduces blood volume and can trigger a faster or irregular heartbeat. Staying well hydrated and eating small meals may help reduce both gastrointestinal symptoms and any related palpitations.

Saxenda has shown cardiovascular benefits in some studies, but people with existing arrhythmias or heart conditions need careful evaluation before starting liraglutide. A clinician will weigh your individual risk factors. Doctronic offers 24/7 consultations to help you review your medical history before beginning any new medication.

The Bottom Line

Heart palpitations are a possible, though uncommon, experience for people taking Saxenda (liraglutide). The drug can modestly raise resting heart rate, and early side effects like nausea may cause dehydration that compounds the problem. Most palpitations are mild and resolve on their own, but any palpitation paired with chest pain, fainting, or rapid heart rate needs prompt medical evaluation. Doctronic, the first AI legally authorized to practice medicine in Utah, offers free AI consultations and $39 video visits around the clock so you can get answers fast. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get medical advice

Chat Now